Skip to main content
. 2007 Jun 30;98(9):1394–1401. doi: 10.1111/j.1349-7006.2007.00537.x

Figure 2.

Figure 2

Effects of paclitaxel (PTX) on PC14PE6 and NCI‐H441 tumor xenografts. (A, B) The bioluminescence intensity in (A) PC14PE6/EF‐Luc and (B) NCI‐H441/EF‐Luc xenografts treated with PTX (PTX) and untreated (control) were monitored every other day and quantified as photons/s/ROI. Each group consisted of at least 8 mice and the average photon counts ± SD of each group are shown. *P < 0.05 versus control group of NCI‐H441 xenografts. (C, D) Survival rate of (C) PC14PE6/EF‐Luc and (D) NCI‐H441/EF‐Luc orthotopic xenografts treated with PTX (PTX) and untreated (control) are shown. **P < 0.01 versus control group of NCI‐H441 xenografts. The median survival time of each treatment group is shown in Table 1.